Welcome, visitor! [ Register | Login rss Google+ facebook twitter LinkedIn Pinterest

Mitsubishi Tanabe Pharma to Buy Israeli Drug Maker “NeuroDerm” for Record $1.1 Billion

| Investment & Acquisition, Israeli | 07/27/2017

NeuroDerm_Israel21c

Japanese Firm to Buy Israeli Drug Maker for Record $1.1 Billion

Date: July 26, 2017
Source: The Tower by ISRAEL21c

NeuroDerm, an Israeli clinical-stage pharmaceutical company developing next-generation treatments for central nervous system disorders, will be acquired for $1.1 billion in cash by Japanese company Mitsubishi Tanabe Pharma Corporation.

Continue reading »

  • Japanese Companies - ""...

  • Japanese Companies - ""...

  • Japanese Companies - ""...

  • Japanese Companies - ""...

  • Japanese Companies - ""...

Group Sites

  • Ad 1
  • Ad 2
  • Ad 3
  • Ad 4